| Name | Title | Contact Details |
|---|
We are committed to helping people with severe, chronic cardiovascular diseases realize the promise of patient-specific, expanded multicellular therapy.
MeMed is a host response, med-tech & bioconvergence company, offering innovative diagnostic host response tests that address complex clinical dilemmas & improve patient outcomes.
Farkas IRM is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mirus Corporation is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OncoResponse Inc., a privately held immuno-oncology company, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to the discovery of cancer therapeutics.